SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-05-022888
Filing Date
2005-05-12
Accepted
2005-05-12 14:13:26
Documents
11
Period of Report
2005-06-30
Effectiveness Date
2005-05-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A a05-8795_1def14a.htm DEF 14A 752595
2 GRAPHIC g87952bcimage002.jpg GRAPHIC 244
3 GRAPHIC g87952bcimage004.jpg GRAPHIC 308
4 GRAPHIC g87952bcimage005.jpg GRAPHIC 306
5 GRAPHIC g87952bcimage007.jpg GRAPHIC 507
6 GRAPHIC g87952bcimage009.jpg GRAPHIC 237
7 GRAPHIC g87951dcimage002.gif GRAPHIC 757
8 GRAPHIC g87951dcimage004.gif GRAPHIC 645
9 GRAPHIC g87951dsimage002.gif GRAPHIC 2795
10 GRAPHIC g87951dsimage004.gif GRAPHIC 577
11 GRAPHIC g87951deimage002.gif GRAPHIC 577
  Complete submission text file 0001104659-05-022888.txt   765250
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 05823717
SIC: 2834 Pharmaceutical Preparations